WATERTOWN, Mass. (AP) _ EyePoint Pharmaceuticals (EYPT) on Wednesday reported a loss of $13 million in its second quarter.
On a per-share basis, the Watertown, Massachusetts-based company said it had a loss of 10 cents.
The drug delivery technology company posted revenue of $4.1 million in the period.
The company’s shares closed at 73 cents. A year ago, they were trading at $1.24.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EYPT at https://www.zacks.com/ap/EYPT
The Associated Press
